1Life Technologies™ Proprietary |

AIPLA Winter Meeting PresentationJanuary 2013

2Life Technologies™ Proprietary | L i fe Te c h n o l o g i e s To d ay

1000s of products - Research & Applied Markets

• Consumables and instruments used to sequence and analyze DNA

• Consumables and instruments used to analyze gene functions

• Next generation sequencing

• Consumables for all types of sample preparation, gene expression and cellular research

• Cell culture media for drug development• Molecular and cell biology reagents• Endpoint PCR benchtop instruments and consumables

• BioProduction• Forensic Testing• Capillary Eletrophoresis and qPCR instruments• Animal Health and Food Safety• Medical Sciences

Genetic Analysis

Applied Sciences

Research Consumables

3Life Technologies™ Proprietary |

Strong Competitive Advantages In All End Markets

• Broad product offerings• Strong, most scientifically cited brands

• Comprehensive solutions• Customizable e-Procurement offerings• World-renowned media formulation for biotech

• Technology provider to diagnostic laboratories

• Established protocols in Forensics• Growing number of offerings for AgBio,

Food & Safety, Synthetic Genomics

Academic / Government

Pharma /Biotech

CommercialApplications

Hospital / Clinics

4Life Technologies™ Proprietary | 2. Lead product innovati on

Offering a Full Range of Solutions for the Life Science Market

CE Sequencing qPCR Best-in-class reagents and consumables

Confirmation / Validation Sample prep andfollow-on experiments

Next GenerationSequencing

Discovery

5Life Technologies™ Proprietary |

• Launched Pervenio™ lung cancer test service in Q3

• Northern California based genomics testing provider

• CLIA certified lab in all 50 states and physician/patient software infrastructure

Building Our Diagnostics Franchise

• Positions LIFE as a partner of choice for drug and companion diagnostic development

6Life Technologies™ Proprietary |

Life Tech has a Large Patent Porfolio

• Broad and deep patent portfolio

• Over 4,000 owned or controlled patents

• Relevant to molecular diagnostics

• Underlying technologies

• Sample prep

• Genetic analysis

• Methods, reagents and instruments

• Specific molecular Dx assays [developing]

Life Tech’s portfolio relates to underlying molecular Dx technologies